Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
This report highlights the potential utility of loxapine in individuals with schizoaffective disorder intolerant to standard mood-stabilizing and antipsychotic medications.PMID:37332889 | PMC:PMC10276762 | DOI:10.1155/2023/8887553 (Source: Case Reports in Psychiatry)
Source: Case Reports in Psychiatry - June 19, 2023 Category: Psychiatry Authors: David S Im Marina Capitanov Amy M VandenBerg Source Type: research
A Case of New-Onset Obsessive-Compulsive Disorder and Schizophrenia in a 14-Year-Old Male following the COVID-19 Pandemic
This report details a case of new-onset obsessive-compulsive disorder (OCD) and schizophrenia following the COVID-19 pandemic. The novelty of this case lies in the onset of the patient's symptoms in the context of the COVID-19 pandemic, without prior predisposing risks in the environmental, social, or biological aspects. We provided therapeutic treatment to the patient in an inpatient setting, while examining the patient to decipher the root cause of his symptoms. While there is substantial data suggesting exacerbations of OCD during the COVID-19 pandemic in the general population and a new onset of schizophrenia due to th...
Source: Case Reports in Psychiatry - June 19, 2023 Category: Psychiatry Authors: Daniel Bibawy Jennyferd Barco Yeghia Sounboolian Priya Atodaria Source Type: research
Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
This report highlights the potential utility of loxapine in individuals with schizoaffective disorder intolerant to standard mood-stabilizing and antipsychotic medications.PMID:37332889 | PMC:PMC10276762 | DOI:10.1155/2023/8887553 (Source: Case Reports in Psychiatry)
Source: Case Reports in Psychiatry - June 19, 2023 Category: Psychiatry Authors: David S Im Marina Capitanov Amy M VandenBerg Source Type: research
A Case of New-Onset Obsessive-Compulsive Disorder and Schizophrenia in a 14-Year-Old Male following the COVID-19 Pandemic
This report details a case of new-onset obsessive-compulsive disorder (OCD) and schizophrenia following the COVID-19 pandemic. The novelty of this case lies in the onset of the patient's symptoms in the context of the COVID-19 pandemic, without prior predisposing risks in the environmental, social, or biological aspects. We provided therapeutic treatment to the patient in an inpatient setting, while examining the patient to decipher the root cause of his symptoms. While there is substantial data suggesting exacerbations of OCD during the COVID-19 pandemic in the general population and a new onset of schizophrenia due to th...
Source: Case Reports in Psychiatry - June 19, 2023 Category: Psychiatry Authors: Daniel Bibawy Jennyferd Barco Yeghia Sounboolian Priya Atodaria Source Type: research
Serotonin Syndrome with Monotherapy of Low-Dose Sertraline in an Adult Patient with Autism Spectrum Disorder
We present a case of a 32-year-old male with a history of autism spectrum disorder and depressive disorder who presented to the emergency department with restless agitation, neuromuscular excitability, and autonomic instability. He had been prescribed sertraline 50 mg which he had taken daily as prescribed for 4 days. On the fourth day, he presented to the emergency department with diffuse muscle stiffness, upper extremity tremors, ocular clonus, and inducible ankle clonus. He was diagnosed with probable serotonin syndrome utilizing Hunter's criteria. Patient's symptoms resolved within 24 hours with intravenous fluids, lor...
Source: Case Reports in Psychiatry - June 16, 2023 Category: Psychiatry Authors: Rohit Madan Jody Platto Senthil Rajaram Manoharan Varun Monga Source Type: research
Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment
We report on a depressed woman who developed abnormal thyroid biochemical laboratory reports during fluoxetine therapy. After changing to the serotonin and norepinephrine reuptake inhibitor (SNRI) venlafaxine, the thyroid laboratory reports were normalized. In light of this, we wish to alert treating clinicians to this potential significant adverse effect.PMID:37215167 | PMC:PMC10195165 | DOI:10.1155/2023/7170564 (Source: Case Reports in Psychiatry)
Source: Case Reports in Psychiatry - May 22, 2023 Category: Psychiatry Authors: Huijuan Liao David S Rosenthal Salini C Kumar Source Type: research
